# TO Title: Contract Orientation & Kickoff Meeting for Preclinical Services for PREVENTBase IDIQ Title: PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate End

> **NIH NIH N01** · UNIVERSITY OF TX MD ANDERSON CAN CTR · 2024 · $3,500

## Abstract

PREVENT EFFICACY Pool: This contract supports the PREVENT Cancer Preclinical Drug Development Program, which provides a structured approach to drug and vaccine development, from discovery to the clinic. This contract is a part of a multiple-award Indefinite Delivery Indefinite Quantity (IDIQ) pool to procure services related to Preclinical Efficacy and Intermediate Endpoint Biomarkers, which is also referred to as the Efficacy Pool.

## Key facts

- **NIH application ID:** 11020345
- **Project number:** 75N91024D00004-0-759102400001-1
- **Recipient organization:** UNIVERSITY OF TX MD ANDERSON CAN CTR
- **Principal Investigator:** Eduardo Vilar Sanchez
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $3,500
- **Award type:** —
- **Project period:** 2024-01-25 → 2029-01-24

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11020345

## Citation

> US National Institutes of Health, RePORTER application 11020345, TO Title: Contract Orientation & Kickoff Meeting for Preclinical Services for PREVENTBase IDIQ Title: PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate End (75N91024D00004-0-759102400001-1). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/11020345. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*